LGP.ASX: Implementation of Merger between LGP and Cannatrek

Implementation of Merger between LGP and Cannatrek

Stock	Little Green Pharma Ltd (LGP.ASX)
Release Time	1 Jun 2026, 9:32 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

LGP and Cannatrek Merger Implementation Announced

Key Points

Successful implementation of the merger between LGP and Cannatrek
LGP and Cannatrek shareholders now hold ~39.5% and ~60.5% of LGP respectively
New leadership roles and board changes following the merger

Full Summary

Little Green Pharma Ltd (ASX: LGP) has announced the successful implementation of its previously announced scheme of arrangement to acquire 100% of Cannatrek Ltd. The merger brings together two established Australian medicinal cannabis businesses, creating a leading international group with vertically integrated operations. The merger was approved by Cannatrek shareholders and the Federal Court of Australia. Following the merger, LGP ordinary shares and new LGP contingent value shares have been issued to Cannatrek shareholders. The new LGP Cannatrek Group is expected to benefit from operational and strategic synergies across various functions and will be well-positioned for further international expansion. Leadership changes include Brent Dennison as Independent Non-Executive Chair, Paul Long as Group CEO, and several new and retiring board members.